![Yoshitaka Tanaka](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yoshitaka Tanaka
Direttore Tecnico/Scientifico/R&S presso NISSUI PHARMACEUTICAL CO., LTD.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Tokuya Ono | M | 61 | 38 anni | |
Wahei Toki | M | 69 | 45 anni | |
Masayuki Aso | M | - |
CellGenTech, Inc.
![]() CellGenTech, Inc. Pharmaceuticals: MajorHealth Technology CellGenTech, Inc. engages in the research and development of drugs for new gene therapy and regenerative medicine. It offers adipocyte-based medicine, technology for the development of gene/cell therapies. It also provides protein supplemental therapy solutions in the areas of hereditary diseases; orphan diseases; intractable diseases, such as lysosome and hemophilia; diabetics; arteriosclerotic diseases, and cancer or degenerative neuropathies. The company was founded by Masayuki Aso on October 20, 2003 and is headquartered in Chiba, Japan. | 21 anni |
Eiichi Shibasaki | M | 68 | 27 anni | |
Kazunori Kato | M | 61 | 8 anni | |
Takahiro Shimada | M | - |
CellGenTech, Inc.
![]() CellGenTech, Inc. Pharmaceuticals: MajorHealth Technology CellGenTech, Inc. engages in the research and development of drugs for new gene therapy and regenerative medicine. It offers adipocyte-based medicine, technology for the development of gene/cell therapies. It also provides protein supplemental therapy solutions in the areas of hereditary diseases; orphan diseases; intractable diseases, such as lysosome and hemophilia; diabetics; arteriosclerotic diseases, and cancer or degenerative neuropathies. The company was founded by Masayuki Aso on October 20, 2003 and is headquartered in Chiba, Japan. | 19 anni |
Shin Saito | M | 62 | 7 anni | |
Masami Tanio | M | - |
CellGenTech, Inc.
![]() CellGenTech, Inc. Pharmaceuticals: MajorHealth Technology CellGenTech, Inc. engages in the research and development of drugs for new gene therapy and regenerative medicine. It offers adipocyte-based medicine, technology for the development of gene/cell therapies. It also provides protein supplemental therapy solutions in the areas of hereditary diseases; orphan diseases; intractable diseases, such as lysosome and hemophilia; diabetics; arteriosclerotic diseases, and cancer or degenerative neuropathies. The company was founded by Masayuki Aso on October 20, 2003 and is headquartered in Chiba, Japan. | 18 anni |
Seiji Tanaka | M | - | - | |
Tatsuo Ishii | M | - | - | |
Shinya Yamashita | M | - | 3 anni | |
Tetsuya Mishima | M | - |
CellGenTech, Inc.
![]() CellGenTech, Inc. Pharmaceuticals: MajorHealth Technology CellGenTech, Inc. engages in the research and development of drugs for new gene therapy and regenerative medicine. It offers adipocyte-based medicine, technology for the development of gene/cell therapies. It also provides protein supplemental therapy solutions in the areas of hereditary diseases; orphan diseases; intractable diseases, such as lysosome and hemophilia; diabetics; arteriosclerotic diseases, and cancer or degenerative neuropathies. The company was founded by Masayuki Aso on October 20, 2003 and is headquartered in Chiba, Japan. | 19 anni |
Chieko Yamazaki | F | - | - | |
Junichiro Yonekura | M | 43 | - | |
Tetsuji Kawamura | M | - | - | |
Takahisa Ueno | M | - | - | |
Yuichi Oku | M | - | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Giappone | 17 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Yoshitaka Tanaka
- Contatti personali